Kana N Miyata
Overview
Explore the profile of Kana N Miyata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang S, Liao M, Miyata K, Pang Y, Zhao X, Peng J, et al.
Transl Res
. 2025 Jan;
277:13-26.
PMID: 39756674
Renal hedgehog interacting protein (Hhip) activates sodium-glucose cotransporter 2 (Sglt2) expression and promotes tubular senescence in murine diabetic kidney disease (DKD), yet its underlying mechanism(s) are poorly understood. Here we...
2.
Yang W, Su K, Liao M, Zhou J, Peng J, Hebert M, et al.
Diabetes
. 2025 Jan;
PMID: 39752561
The role of the intrarenal renin-angiotensin system (iRAS) in diabetic kidney disease (DKD) progression remains unclear. In this study, we generated mice with renal tubule-specific deletion of angiotensinogen (Agt; RT-Agt-/-)...
3.
Kalishman A, Ashai K, Philipneri M, Miyata K
Perit Dial Int
. 2024 Nov;
:8968608241297860.
PMID: 39506327
No abstract available.
4.
Lentine K, Miyata K, Lam N, Joseph C, McAdams-DeMarco M, Bae S, et al.
Clin Transplant
. 2024 Apr;
38(4):e15257.
PMID: 38563475
Background: Recent clinical trials demonstrate benefits of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with chronic kidney disease, but data on use in kidney transplant (KTx) recipients are limited. Methods: We...
5.
Liao M, Lo C, Pang Y, Yang W, Su K, Zhao X, et al.
Transl Res
. 2024 Jan;
267:1-9.
PMID: 38195017
Heterogeneous nuclear ribonucleoprotein F (HnRNP F) is a key regulator for nucleic acid metabolism; however, whether HnRNP F expression is important in maintaining podocyte integrity is unclear. Nephroseq analysis from...
6.
Hoang S, Pujar T, Bellorin-Font E, Edwards J, Miyata K
CEN Case Rep
. 2023 Oct;
13(3):194-198.
PMID: 37897631
Ifosfamide, a cytotoxic antineoplastic drug, can induce rare complications of Fanconi syndrome and nephrogenic diabetes insipidus (DI). Ifosfamide-induced Fanconi syndrome tends to occur in patients with certain risk factors including...
7.
Su K, Zhao S, Yang W, Lo C, Chenier I, Liao M, et al.
Antioxidants (Basel)
. 2023 Sep;
12(9).
PMID: 37760019
The role(s) of nuclear factor erythroid 2-related factor 2 (NRF2) in diabetic kidney disease (DKD) is/are controversial. We hypothesized that Nrf2 deficiency in type 2 diabetes (T2D) db/db mice (db/db...
8.
9.
Tamer M, Brink D, Bastani B, Miyata K
Nephrology (Carlton)
. 2023 Feb;
28(4):255-256.
PMID: 36760027
No abstract available.
10.
Miyata K, Zhang S, Chan J
Glomerular Dis
. 2023 Feb;
1(1):21-33.
PMID: 36751486
Background: Recent studies show that sodium-glucose cotransporter 2 inhibitors (SGLT2i), originally approved for glycemic control in patients with type 2 diabetes, also exert renoprotective effects independently from effects on dysglycemia....